oral semaglutide nejm 🚨 25 mg delivers double-digit weight loss in OASIS-4 (Phase 3 trial) - SELECT Trial

Semaglutide, known by the brand names Wegovy and Ozempic, are also GLP-1 receptor agonists

This early window reflects the medication's rapid absorption into the bloodstream and activation of GLP-1 signaling pathways in your chemoreceptor trigger zonethe brain region controlling nausea sensation

Fat tissue Semaglutide also enhances energy expenditure

With better cardiovascular health, you can enjoy a more active lifestyle and reduce the risk of serious health complications

Are there specific clinical criteria required for approval (e.g., BMI thresholds, sustained weight requirements, step therapy such as participation in a weight management program)

Participants who took Semaglutide lost 15% of their body weight on average, while those who took liraglutide lost around 6%